These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

712 related articles for article (PubMed ID: 36302755)

  • 1. Liquid biopsy in gastric cancer: predictive and prognostic biomarkers.
    Zhang Z; Wu H; Chong W; Shang L; Jing C; Li L
    Cell Death Dis; 2022 Oct; 13(10):903. PubMed ID: 36302755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and predictive blood biomarkers in gastric cancer and the potential application of circulating tumor cells.
    Li TT; Liu H; Yu J; Shi GY; Zhao LY; Li GX
    World J Gastroenterol; 2018 Jun; 24(21):2236-2246. PubMed ID: 29881233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid biopsy and their application progress in head and neck cancer: focus on biomarkers CTCs, cfDNA, ctDNA and EVs.
    Meng Y; Bian L; Zhang M; Bo F; Lu X; Li D
    Biomark Med; 2020 Oct; 14(14):1393-1404. PubMed ID: 33073579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer.
    Zhou H; Zhu L; Song J; Wang G; Li P; Li W; Luo P; Sun X; Wu J; Liu Y; Zhu S; Zhang Y
    Mol Cancer; 2022 Mar; 21(1):86. PubMed ID: 35337361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid biopsy in breast cancer: A comprehensive review.
    Alimirzaie S; Bagherzadeh M; Akbari MR
    Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid biopsy in ovarian cancer: recent advances on circulating tumor cells and circulating tumor DNA.
    Giannopoulou L; Kasimir-Bauer S; Lianidou ES
    Clin Chem Lab Med; 2018 Jan; 56(2):186-197. PubMed ID: 28753534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid biopsy in ovarian cancer.
    Giannopoulou L; Lianidou ES
    Adv Clin Chem; 2020; 97():13-71. PubMed ID: 32448432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical application and detection techniques of liquid biopsy in gastric cancer.
    Ma S; Zhou M; Xu Y; Gu X; Zou M; Abudushalamu G; Yao Y; Fan X; Wu G
    Mol Cancer; 2023 Jan; 22(1):7. PubMed ID: 36627698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Different Facets of Liquid Biopsy: A Kaleidoscopic View.
    Eslami-S Z; Cortés-Hernández LE; Cayrefourcq L; Alix-Panabières C
    Cold Spring Harb Perspect Med; 2020 Jun; 10(6):. PubMed ID: 31548226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid biopsy: Circulating exosomal long noncoding RNAs in cancer.
    Jiang N; Pan J; Fang S; Zhou C; Han Y; Chen J; Meng X; Jin X; Gong Z
    Clin Chim Acta; 2019 Aug; 495():331-337. PubMed ID: 31054913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential of liquid biopsy in the management of cancer patients.
    Markou A; Tzanikou E; Lianidou E
    Semin Cancer Biol; 2022 Sep; 84():69-79. PubMed ID: 35331850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges.
    Seyhan AA
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid biopsy derived circulating tumor cells and circulating tumor DNA as novel biomarkers in hepatocellular carcinoma.
    Temraz S; Nasr R; Mukherji D; Kreidieh F; Shamseddine A
    Expert Rev Mol Diagn; 2022 May; 22(5):507-518. PubMed ID: 35758097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes.
    Yang WY; Feng LF; Meng X; Chen R; Xu WH; Hou J; Xu T; Zhang L
    Expert Rev Mol Diagn; 2020 Dec; 20(12):1213-1227. PubMed ID: 33232189
    [No Abstract]   [Full Text] [Related]  

  • 15. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?
    Asante DB; Calapre L; Ziman M; Meniawy TM; Gray ES
    Cancer Lett; 2020 Jan; 468():59-71. PubMed ID: 31610267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in liquid biopsy using circulating tumor cells and circulating cell-free tumor DNA for detection and monitoring of breast cancer.
    Zhang X; Ju S; Wang X; Cong H
    Clin Exp Med; 2019 Aug; 19(3):271-279. PubMed ID: 31190187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating miRNA and circulating tumor DNA application as liquid biopsy markers in gastric cancer.
    Shaker F; Razi S; Rezaei N
    Clin Biochem; 2024 Jul; 129():110767. PubMed ID: 38705444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-Free DNA in the Liquid Biopsy Context: Role and Differences Between ctDNA and CTC Marker in Cancer Management.
    Fici P
    Methods Mol Biol; 2019; 1909():47-73. PubMed ID: 30580422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Tumor DNA in Gastric Adenocarcinoma: Future Clinical Applications and Perspectives.
    Grizzi G; Salati M; Bonomi M; Ratti M; Holladay L; De Grandis MC; Spada D; Baiocchi GL; Ghidini M
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid biopsy: current technology and clinical applications.
    Nikanjam M; Kato S; Kurzrock R
    J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.